Profilo
David C.
Dalgarno is the founder.
He founded Theseus Pharmaceuticals, Inc. in 2017 and served as the Chief Technical Officer from 2018 to 2022.
Dr. Dalgarno also held the position of Scientist at Schering-Plough Corp.
and Vice President-Research Technologies at ARIAD Pharmaceuticals, Inc. from 1992 to 2017.
Dr. Dalgarno obtained undergraduate and doctorate degrees from the University of Oxford.
Precedenti posizioni note di David C. Dalgarno
| Società | Posizione | Fine |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2017 |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | - |
| THESEUS PHARMACEUTICALS, INC. | Fondatore | - |
Formazione di David C. Dalgarno
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and supplies drugs for cancer patients | Health Technology |
















